Rapid Detection of Bacterial Resistance by MALDI-TOF MS and Antibiotic Savings

Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)

NCT01597973 ·Status: COMPLETED ·Phase: PHASE3

Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations

NCT04573894 ·Status: COMPLETED

Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination

NCT03963297 ·Status: COMPLETED

Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia

NCT00326287 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae

NCT02583373 ·Status: COMPLETED ·Phase: PHASE1

Reduction of Bacteriuria in Subjects Practicing Intermittent Catheterization

NCT01143116 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli

NCT00300560 ·Status: UNKNOWN ·Phase: PHASE3

Impact of Performing a Rapid Antibiotic Susceptibility Test on Antibiotic Therapy Adaptation in Adult Patients with Enterobacterales Bacteremia

NCT06425367 ·Status: RECRUITING ·Phase: NA

Effect of dRAST on Treatment for Bacteremia in Patients With Hematologic Diseases

NCT03611257 ·Status: COMPLETED ·Phase: NA

Description of Lung Transplant Patients With Microbiologically Documented Stenotrophomonas Maltophilia Pneumonia and Impact of Treatment on Outcome

NCT05193058 ·Status: UNKNOWN

PCR Technic Evaluation in the Microbial Diagnostic of Septicemia in Hemodialysis Patients With Catheter.

NCT04026035 ·Status: COMPLETED

Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli

NCT02474706 ·Status: TERMINATED ·Phase: PHASE4

Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections

NCT06843668 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes

NCT06069206 ·Status: COMPLETED ·Phase: NA

Efficacy and Mortality of a Loading Dose of Colistin in Critical Ill Patients

NCT02117986 ·Status: UNKNOWN ·Phase: PHASE4

Identification of Clinical, Genetic and Immunological Factors Involved in the Development of Severe Bacterial Infections in Pediatrics

NCT07111793 ·Status: RECRUITING ·Phase: NA

Factors Associated With Mortality in Streptococcal Anginosus Bacteremia

NCT07343167 ·Status: RECRUITING

Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers

NCT01026740 ·Status: COMPLETED ·Phase: PHASE1

Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections

NCT03510351 ·Status: COMPLETED

A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects

NCT02439359 ·Status: COMPLETED ·Phase: PHASE1

Validation of Biomarkers Performance to Reduce Antibiotics overUse in newBorns With Suspected Clinical Signs of InfectionS

NCT06058819 ·Status: RECRUITING

Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia

NCT05613322 ·Status: TERMINATED

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

NCT00210899 ·Status: COMPLETED ·Phase: PHASE3

Resistant Bacteria in Children in France

NCT06036628 ·Status: COMPLETED

Ceftobiprole in Hospital Acquired Pneumonia

NCT00210964 ·Status: COMPLETED ·Phase: PHASE3